» Articles » PMID: 25685828

The Versatile Functions of Sox9 in Development, Stem Cells, and Human Diseases

Overview
Journal Genes Dis
Date 2015 Feb 17
PMID 25685828
Citations 183
Authors
Affiliations
Soon will be listed here.
Abstract

The transcription factor Sox9 was first discovered in patients with campomelic dysplasia, a haploinsufficiency disorder with skeletal deformities caused by dysregulation of expression during chondrogenesis. Since then, its role as a cell fate determiner during embryonic development has been well characterized; expression differentiates cells derived from all three germ layers into a large variety of specialized tissues and organs. However, recent data has shown that ectoderm- and endoderm-derived tissues continue to express in mature organs and stem cell pools, suggesting its role in cell maintenance and specification during adult life. The versatility of Sox9 may be explained by a combination of post-transcriptional modifications, binding partners, and the tissue type in which it is expressed. Considering its importance during both development and adult life, it follows that dysregulation of Sox9 has been implicated in various congenital and acquired diseases, including fibrosis and cancer. This review provides a summary of the various roles of Sox9 in cell fate specification, stem cell biology, and related human diseases. Ultimately, understanding the mechanisms that regulate Sox9 will be crucial for developing effective therapies to treat disease caused by stem cell dysregulation or even reverse organ damage.

Citing Articles

SOX9 Overexpression Ameliorates Metabolic Dysfunction-associated Steatohepatitis Through Activation of the AMPK Pathway.

Deng J, Ding K, Liu S, Chen F, Huang R, Xu B J Clin Transl Hepatol. 2025; 13(3):189-199.

PMID: 40078197 PMC: 11894392. DOI: 10.14218/JCTH.2024.00197.


Distinct gene regulatory dynamics drive skeletogenic cell fate convergence during vertebrate embryogenesis.

Wang M, Di Pietro-Torres A, Feregrino C, Luxey M, Moreau C, Fischer S Nat Commun. 2025; 16(1):2187.

PMID: 40038298 PMC: 11880379. DOI: 10.1038/s41467-025-57480-8.


Silicosis: from pathogenesis to therapeutics.

Yang B, Liu X, Peng C, Meng X, Jia Q Front Pharmacol. 2025; 16:1516200.

PMID: 39944632 PMC: 11813918. DOI: 10.3389/fphar.2025.1516200.


Continuous cell type diversification throughout the embryonic and postnatal mouse visual cortex development.

Gao Y, van Velthoven C, Lee C, Thomas E, Bertagnolli D, Carey D bioRxiv. 2025; .

PMID: 39829740 PMC: 11741437. DOI: 10.1101/2024.10.02.616246.


Missense variants weakening a SOX9 phosphodegron linked to odontogenesis defects, scoliosis, and other skeletal features.

Ettaki I, Haseeb A, Karvande A, Amalou G, Saih A, AitRaise I HGG Adv. 2025; 6(2):100404.

PMID: 39797402 PMC: 11834033. DOI: 10.1016/j.xhgg.2025.100404.


References
1.
Kopp J, von Figura G, Mayes E, Liu F, Dubois C, Morris 4th J . Identification of Sox9-dependent acinar-to-ductal reprogramming as the principal mechanism for initiation of pancreatic ductal adenocarcinoma. Cancer Cell. 2012; 22(6):737-50. PMC: 3568632. DOI: 10.1016/j.ccr.2012.10.025. View

2.
Taylor K, Labonne C . SoxE factors function equivalently during neural crest and inner ear development and their activity is regulated by SUMOylation. Dev Cell. 2005; 9(5):593-603. DOI: 10.1016/j.devcel.2005.09.016. View

3.
Govindarajan V, Overbeek P . FGF9 can induce endochondral ossification in cranial mesenchyme. BMC Dev Biol. 2006; 6:7. PMC: 1395304. DOI: 10.1186/1471-213X-6-7. View

4.
Carpino G, Cardinale V, Onori P, Franchitto A, Berloco P, Rossi M . Biliary tree stem/progenitor cells in glands of extrahepatic and intraheptic bile ducts: an anatomical in situ study yielding evidence of maturational lineages. J Anat. 2011; 220(2):186-99. PMC: 3275774. DOI: 10.1111/j.1469-7580.2011.01462.x. View

5.
Martini S, Bernoth K, Main H, Ortega G, Lendahl U, Just U . A critical role for Sox9 in notch-induced astrogliogenesis and stem cell maintenance. Stem Cells. 2013; 31(4):741-51. DOI: 10.1002/stem.1320. View